ES2168297T3 - Fenilalanina-amonio-liasa estabilizada. - Google Patents

Fenilalanina-amonio-liasa estabilizada.

Info

Publication number
ES2168297T3
ES2168297T3 ES94919559T ES94919559T ES2168297T3 ES 2168297 T3 ES2168297 T3 ES 2168297T3 ES 94919559 T ES94919559 T ES 94919559T ES 94919559 T ES94919559 T ES 94919559T ES 2168297 T3 ES2168297 T3 ES 2168297T3
Authority
ES
Spain
Prior art keywords
liasa
phenylalanine
stabilized
ammonia
liasen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94919559T
Other languages
English (en)
Inventor
Peter Eigtved
Ib Groth Clausen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Application granted granted Critical
Publication of ES2168297T3 publication Critical patent/ES2168297T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lubricants (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A LA ESTABILIZACION DE LIASA DE AMONIACOS FENILALANINA CONTRA LA DEGRADACION PROTEOLITICA MEDIANTE LA MODIFICACION QUIMICA, POR EJEMPLO CON AGENTES RETICULANTES, O MEDIANTE LA MODIFICACION GENETICA, UNA VARIANTE DE LIASA DE AMONIACOS FENILALANINA, UN METODO DE PREPARACION DE LA VARIANTE Y UNA COMPOSICION FARMACEUTICA QUE CONTIENE DICHA LIASA.
ES94919559T 1993-06-25 1994-06-09 Fenilalanina-amonio-liasa estabilizada. Expired - Lifetime ES2168297T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93755A DK75593D0 (es) 1993-06-25 1993-06-25

Publications (1)

Publication Number Publication Date
ES2168297T3 true ES2168297T3 (es) 2002-06-16

Family

ID=8097168

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94919559T Expired - Lifetime ES2168297T3 (es) 1993-06-25 1994-06-09 Fenilalanina-amonio-liasa estabilizada.

Country Status (10)

Country Link
US (1) US5753487A (es)
EP (1) EP0703788B1 (es)
AT (1) ATE209044T1 (es)
AU (1) AU7067594A (es)
CA (1) CA2165281A1 (es)
DE (1) DE69429167T2 (es)
DK (2) DK75593D0 (es)
ES (1) ES2168297T3 (es)
PT (1) PT703788E (es)
WO (1) WO1995000171A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010006635A1 (en) 1995-09-29 2001-07-05 D. Clark Bennett Use of heparinase to decrease inflammatory responses
US5647368A (en) * 1996-02-28 1997-07-15 Xillix Technologies Corp. Imaging system for detecting diseased tissue using native fluorsecence in the gastrointestinal and respiratory tract
US6190883B1 (en) 1998-09-09 2001-02-20 Novo Nordisk A/S Method for the production of heterologous polypeptides in transformed yeast cells
US6521748B2 (en) 1999-08-06 2003-02-18 E. I. Du Pont De Nemours And Company Polynucleotide encoding a mutant Rhodotorula glutinis tyrosine ammonia lyase polypeptide
US6368837B1 (en) 1999-08-06 2002-04-09 E. I. Du Pont Nemours And Company Bioproduction of para-hydroxycinnamic acid
EP1372703A2 (en) * 2001-02-16 2004-01-02 Ibex Technologies Matrix stabilized enzyme crystals and methods of use
CA2580679A1 (en) * 2004-09-17 2006-03-30 Biomarin Pharmaceutical Inc. Variants and chemically-modified variants of phenylalanine ammonia-lyase
US20090038023A1 (en) 2005-03-10 2009-02-05 Verenium Corporation Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
US7534595B2 (en) 2006-06-12 2009-05-19 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7531341B1 (en) 2006-06-12 2009-05-12 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US7537923B2 (en) * 2007-08-17 2009-05-26 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
ES2671710T3 (es) 2008-05-02 2018-06-08 Novadaq Technologies ULC Métodos para la producción y uso de eritrocitos cargados con sustancias para la observación y el tratamiento de la hemodinámica microvascular
US9376659B2 (en) 2008-07-24 2016-06-28 Arch Personal Care Products, L.P. Personal care composition containing yeast/polyphenol ferment extract
WO2010014225A2 (en) 2008-07-30 2010-02-04 Biomarin Pharmaceutical Inc. Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
HUE039516T2 (hu) 2010-02-04 2019-01-28 Biomarin Pharm Inc Eljárás prokarióta fenilalanin-liáz variánsok tisztítására
WO2012003336A2 (en) 2010-06-30 2012-01-05 Codexis, Inc. Chemically modified carbonic anhydrases useful in carbon capture systems
US10278585B2 (en) 2012-06-21 2019-05-07 Novadaq Technologies ULC Quantification and analysis of angiography and perfusion
SI2986722T1 (sl) 2013-04-18 2019-07-31 Codexis, Inc. Umetni polipeptidi fenilalanin amonija liaze
WO2016049756A1 (en) 2014-09-29 2016-04-07 Novadaq Technologies Inc. Imaging a target fluorophore in a biological material in the presence of autofluorescence
EP3915467A1 (en) 2014-10-09 2021-12-01 Novadaq Technologies ULC Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
JP6931705B2 (ja) 2017-02-10 2021-09-08 ノバダック テクノロジーズ ユーエルシー オープンフィールドハンドヘルド蛍光イメージングシステムおよび方法
SG11201906880VA (en) 2017-02-13 2019-08-27 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH538003A (fr) * 1968-03-29 1973-01-31 Anvar Procédé pour l'obtention d'articles textiles porteurs d'enzymes
IT1096208B (it) * 1978-05-12 1985-08-26 Snam Progetti Composizione adatta alla riduzione del tenore di fenilalanina e metodo impiegante la stessa
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues

Also Published As

Publication number Publication date
DK0703788T3 (da) 2002-05-21
US5753487A (en) 1998-05-19
CA2165281A1 (en) 1995-01-05
AU7067594A (en) 1995-01-17
EP0703788A1 (en) 1996-04-03
DE69429167T2 (de) 2002-07-04
DE69429167D1 (de) 2002-01-03
ATE209044T1 (de) 2001-12-15
DK75593D0 (es) 1993-06-25
PT703788E (pt) 2002-05-31
EP0703788B1 (en) 2001-11-21
WO1995000171A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
ES2168297T3 (es) Fenilalanina-amonio-liasa estabilizada.
ES2148345T3 (es) Composicion farmaceutica con ciclosporina a, un derivado de vitamina e y un emulsionante.
ES2183023T3 (es) Composicion farmaceutica estabilizada con un agente basico.
EP0677048A1 (en) CYCLIC SULPHONES AS INHIBITORS RETROVIRAL PROTEASES.
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
HK1042444A1 (zh) 藥用噴霧製劑
ES500916A0 (es) Un procedimiento para la preparacion y estabilizacion de una composicion blanqueante acuosa que contiene peroxido de hi-drogeno.
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
YU28499A (sh) Novi preparati, lekova rastvorenih u vodi, za dobijanje aerosola bez potisnog gasa
DE69430917D1 (de) 3-l-MENTHOXY-PROPANE-1, 2-DIOL ALS LÖSUNGSVERMITTLER UND EXTERNE ZUBEREITUNG, DIE DIESEN ENTHÄLT
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
NO945036D0 (no) Vandig materiale som inneholder en organisk peroksysyre
AU2001289438A1 (en) Pharmaceutical semi-solid composition of isotretinoin
YU78202A (sh) Tečne formulacije
AU674378B2 (en) Use of 2-amino-6-A-propylamino-4,5,6, 7-tetrahydrobenzothiazole (pramipexol) as an anti-depressantdrug
BR9814523A (pt) "composição farmacêutica contendo cloridrato de bupropion e um estabilizador de ácido inorgânico"
AR028727A1 (es) Una composicion detergente liquida
HUP0001970A2 (hu) Gombaellenes szert és foszfolipidet tartalmazó készítmények
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
ES2178425T3 (es) Agente protector contra el sol.
BR8902892A (pt) Processo para a preparacao de hidrazinas substituidas e composicao inseticida
BR9910454A (pt) Preparações efervescentes
AU4084685A (en) (r) or (s)-4 amino-n (1-phenylethyl) benzamide
HUP9800464A2 (hu) Illatosított fehérítőkészítmények

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 703788

Country of ref document: ES